
    
      The study includes the recruitment of patients with advanced prostate cancer resistant to
      chemical castration This is a multicenter prospective trial randomized phase III This study
      design that includes a double randomizzzazione aims generally demonstrating non-inferiority
      in terms of survival of the suspension dell'ormonoterapia versus the maintenance and / or
      administration of intermittent versus continuous administration of chemotherapy in patients
      with prostate cancer resistant to chemical castration I started to line chemotherapy with
      Docetaxel.
    
  